Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare by Seini Moimoi | Mar 8, 2022 | Portfolio News
Inozyme Pharma Strengthens Management Team with Two Executive Appointments by Seini Moimoi | Mar 8, 2022 | Portfolio News
Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System by Seini Moimoi | Mar 7, 2022 | Portfolio News
Lexeo Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAA-Based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease by Seini Moimoi | Mar 2, 2022 | Portfolio News
Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof of Concept for LOCOcyte™ Platform Technology by Seini Moimoi | Mar 2, 2022 | Portfolio News
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia by Seini Moimoi | Feb 28, 2022 | Portfolio News
Somatus Raises $325M to Deliver Proven Value-Based Kidney Care Model to More Americans with Kidney Disease by Seini Moimoi | Feb 23, 2022 | Portfolio News
LEXEO Therapeutics Announces FDA Clearance of Investigational New Drug Application for LX2006, an AAV-based Gene Therapy Candidate for Friedreich’s Ataxia Cardiomyopathy by Seini Moimoi | Feb 16, 2022 | Portfolio News
Checkmate Pharmaceuticals Appoints Alan Bash as President and CEO by Seini Moimoi | Feb 9, 2022 | Portfolio News
Endeavor BioMedicines Closes $101M Series B Financing To Advance Clinical-Stage Precision Medicine Pipeline by Seini Moimoi | Feb 7, 2022 | Portfolio News
